US FDA urged to explain its approval decisions
25 June 2009
Sue Sutter
The US
FDA should explain its approval or non-approval decisions for medicines when the action is contrary to an advisory panel recommendation, industry and consumer representatives have told the agency's transparency task force.
Stakeholders said the FDA should do a better job of explaining the...
Please Login to read the full article.
25 June 2009
Sue Sutter
Stakeholders said the FDA should do a better job of explaining the...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Lawmakers give 'Super Congress' two cents' worth on big bucks cuts
- US Capitol Capsule: PhRMA hopes Part D savings will be muscle against 'Super Congress' cuts
- US Capitol Capsule: Obama wants one-stop shop for patents, trade & small biz aid
- US Capitol Capsule: Obama pushes for crowdfunding, while SEC panel cautious
COMMENT
Other Informa Comment
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
